Form 8-K - Current report:
SEC Accession No. 0001104659-25-104000
Filing Date
2025-10-30
Accepted
2025-10-30 07:00:39
Documents
12
Period of Report
2025-10-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2529678d1_8k.htm   iXBRL 8-K 27402
  Complete submission text file 0001104659-25-104000.txt   193302

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA lqda-20251027.xsd EX-101.SCH 3014
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE lqda-20251027_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lqda-20251027_pre.xml EX-101.PRE 22358
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2529678d1_8k_htm.xml XML 3652
Mailing Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560
Business Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560 919.328.4400
Liquidia Corp (Filer) CIK: 0001819576 (see all company filings)

EIN.: 851710962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39724 | Film No.: 251432137
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)